Suven Life Sciences trades in green on the BSE

13 Jul 2012 Evaluate

Suven Life Sciences is currently trading at Rs. 15.70, up by 0.20 points or 1.29% from its previous closing of Rs. 15.50 on the BSE.

The scrip opened at Rs. 15.90 and has touched a high and low of Rs. 16.25 and Rs. 15.60 respectively. So far 16232 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 20.35 on 20-Jul-2011 and a 52 week low of Rs. 11.50 on 02-Jan-2012.

Last one week high and low of the scrip stood at Rs. 16.60 and Rs. 14.75 respectively. The current market cap of the company is Rs. 183.27 crore.

The promoters holding in the company stood at 63.44% while Institutions and Non-Institutions held 0.08% and 36.48% respectively.

Suven Life Sciences will be presenting several exciting new results and data presentation from their portfolio of investigational neuroscience new chemical entities (NCEs) at Alzheimer's Association International Conference (AAIC) being held in Vancouver, Canada from July 14 to 19, 2012.

AAIC is the world's largest conference of its kind, bringing together researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders.

Alzheimer's disease is one of the scourges of modern day health care which is the largest and fastest growing unmet medical need and Suven is in the forefront of developing a drug for the treatment of this debilitating disease. Alzheimer's is a dementia that causes problems with memory, thinking and behavior. Alzheimer's is not just a memory loss as everyone thinks but Alzheimer's kills.

Suven has excellent portfolio of new molecules through four mechanisms of action using 5-HT6, 5-HT4, H3 and Neuronal Nicotinic acetylcholine receptors for the treatment of cognitive impairment in Alzheimer's disease symptomatically but also possibly useful in reducing the disease progression. Suven scientists are presenting pre-clinical and clinical data on these molecule and other NCEs on cognitive impairment and memory related disorders.

Suven Life Sciences Share Price

122.40 2.85 (2.38%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...